NCT05931250

Alternating and Direct Current Stimulation for Neuropathic Eye Pain

Alternating and Direct Current Stimulation for the Treatment of Chronic Neuropathic Eye Pain and Cerebral Symptoms: a Pilot Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Neil Lagali · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical intervention is to test if two forms of transcranial current stimulation, transcranial direct current stimulation (tDCS) or transcranial alternating current stimulation (tACS) can alleviate neuropathic eye pain in a sample of 20 patients. The main aims are: * Test if tDCS/tACS can alleviate neuropathic eye pain and/or other cerebral symptoms: brain fatigue, migraine, light sensitivity, etc. * Test if one stimulation method is superior to the other Patients will be treated for a total of fifteen 30-minute stimulation sessions, three times a day over a five-day period, each stimulation separated by approximately 4 hours, with either active tACS or tDCS over the scalp corresponding to primary sensory and motor areas. The patients will have questionnaires to monitor subjective experiences and pupillometry before and after treatment to monitor experimental outcomes.

Detailed description

Brief Summary sufficient

Conditions

• Eye Pain
• Neuropathy, Optic
• Cerebral Injury

Interventions

Type	Name	Description
DEVICE	DC-Stimulator Plus (NeuroConn GmbH, Germany)	Transcranial alternating current stimulation
DEVICE	Sooma direct current stimulator (Sooma, Finland)	Transcranial direct current stimulation

Timeline

• Start date: 2023-06-16
• Primary completion: 2024-12-31
• Completion: 2025-12-31
• First posted: 2023-07-05
• Last updated: 2023-07-06

Locations

1 site across 1 country: Sweden